Nemaura Medical Inc. (NMRD)
OTCMKTS
· Delayed Price · Currency is USD
0.0002
0.00 (0.00%)
At close: Dec 5, 2025
Nemaura Medical Employees
Nemaura Medical had 36 employees as of March 31, 2023. The number of employees increased by 4 or 12.50% compared to the previous year.
Employees
36
Change (1Y)
4
Growth (1Y)
12.50%
Revenue / Employee
n/a
Profits / Employee
-$295,859
Market Cap
8.07K
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Elite Pharmaceuticals | 68 |
| Glass House Brands | 374 |
| CytoDyn | 13 |
| American Oncology Network | 1,914 |
| Northwest Biotherapeutics | 25 |
| Silence Therapeutics | 116 |
| Zomedica | 152 |
Nemaura Medical News
- 2 years ago - Important Update on Listing Status and Strategic Direction - GlobeNewsWire
- 2 years ago - Nemaura Medical Inc. Receives Positive Nasdaq Listing Decision - GlobeNewsWire
- 2 years ago - Nemaura Medical Inc. Secures $10 Million Non-Dilutive Credit Facility to Fuel Strategic Growth - GlobeNewsWire
- 2 years ago - Nemaura Launches Direct to Consumer Offering of Metabolic Health Program in Combination with GLP-1 Weight Loss Drugs - GlobeNewsWire
- 2 years ago - Nemaura Medical Reports Fiscal Second Quarter 2024 Results and Provides Business Update - GlobeNewsWire
- 2 years ago - Nemaura Medical Announces Appointment of Mr Nikolai Rozanov as Strategic Adviser in Artificial Intelligence, to Assist in Development of its AI Health Coach, and Strengthen Outcomes in its CGM Based Metabolic and Type 2 Diabetes Programs. - GlobeNewsWire
- 2 years ago - Nemaura Medical to Present at the Maxim Group Emerging Growth in A.I. Conference - GlobeNewsWire
- 2 years ago - Nemaura Medical Provides Update on Nasdaq Compliance Status and Process - GlobeNewsWire